Compound ID | 1517
Class: Glycopeptide
Spectrum of activity: | Gram-positive |
Details of activity: | Inhibits cell wall biosynthesis by binding Lipid II. Exhibits activity against Gram positive bacteria, such as B. subtilis, MRSA, S. epidermidis and E. faecaelis |
Institute where first reported: | University of Debrecen, Hungary |
Year first mentioned: | 2020 |
Highest developmental phase: | Preclinical |
External links: | |
Citation: | https://www.nature.com/articles/s41429-020-0313-6 |